Reply to letter by Frey et al. regarding the article: Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar
Eur Heart J. 2019 Sep 14;40(35):2997.
doi: 10.1093/eurheartj/ehz532.